Iron Homeostasis and Erythropoiesis

Current Topics in Developmental Biology

Volumn 82, Issue , 2008, Pages 141-167

  Wrighting, Diedra M ^a   Andrews, Nancy C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; HEPCIDIN; IRON;

ANIMAL; BONE MARROW; ERYTHROPOIESIS; GENETICS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; METABOLISM; PATHOLOGY; REVIEW;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BONE MARROW; ERYTHROPOIESIS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; IRON;

EID: 39049085307     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0070-2153(07)00006-3     Document Type: Review

References (148)

1. Abboud S., and Haile D.J. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275 (2000) 19906-19912
2. Adamsky K., Weizer O., Amariglio N., Breda L., Harmelin A., Rivella S., Rachmilewitz E., and Rechavi G. Decreased hepcidin mRNA expression in thalassemic mice. Br. J. Haematol. 124 (2004) 123-124
3. Andrews N.C. Iron metabolism: Iron deficiency and iron overload. Annu. Rev. Genomics Hum. Genet. 1 (2000) 75-98
4. Babitt J.L., Huang F.W., Wrighting D.M., Xia Y., Sidis Y., Samad T.A., Campagna J.A., Chung R.T., Schneyer A.L., Woolf C.J., Andrews N.C., and Lin H.Y. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38 (2006) 531-539
5. Babitt J.L., Huang F.W., Xia Y., Sidis Y., Andrews N.C., and Lin H.Y. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117 (2007) 1933-1939
6. Bennett M.J., Lebron J.A., and Bjorkman P.J. Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor. Nature 403 (2000) 46-53
7. Beutler E., Gelbart T., Lee P., Trevino R., Fernandez M.A., and Fairbanks V.F. Molecular characterization of a case of atransferrinemia. Blood 96 (2000) 4071-4074
8. Borregaard N., and Cowland J.B. Neutrophil gelatinase-associated lipocalin, a siderophore-binding eukaryotic protein. Biometals 19 (2006) 211-215
9. Bothwell T., Charlton R., Cook J., and Finch C. "Iron Metabolism." (1979), Blackwell, Oxford, UK 276
10. Bratosin D., Mazurier J., Tissier J.P., Estaquier J., Huart J.J., Ameisen J.C., Aminoff D., and Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 80 (1998) 173-195
11. Breda L., Gardenghi S., Guy E., Rachmilewitz E.A., Weizer-Stern O., Adamsky K., Amariglio N., Rechavi G., Giardina P.J., Grady R.W., and Rivella S. Exploring the role of hepcidin, an antimicrobial and iron regulatory peptide, in increased iron absorption in beta-thalassemia. Ann. NY Acad. Sci. 1054 (2005) 417-422
12. Bridle K.R., Frazer D.M., Wilkins S.J., Dixon J.L., Purdie D.M., Crawford D.H., Subramaniam V.N., Powell L.W., Anderson G.J., and Ramm G.A. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361 (2003) 669-673
13. Britton R.S., Fleming R.E., Parkkila S., Waheed A., Sly W.S., and Bacon B.R. Pathogenesis of hereditary hemochromatosis: Genetics and beyond. Semin. Gastrointest. Dis. 13 (2002) 68-79
14. Buys S.S., Martin C.B., Eldridge M., Kushner J.P., and Kaplan J. Iron absorption in hypotransferrinemic mice. Blood 78 (1991) 3288-3290
15. Camaschella C., Roetto A., Cali A., De Gobbi M., Garozzo G., Carella M., Majorano N., Totaro A., and Gasparini P. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25 (2000) 14-15
16. Canonne-Hergaux F., Zhang A.S., Ponka P., and Gros P. Characterization of the iron transporter DMT1 (NRAMP2/DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 98 (2001) 3823-3830
17. Canonne-Hergaux F., Donovan A., Delaby C., Wang H.J., and Gros P. Comparative studies of duodenal and macrophage ferroportin proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) G156-G163
18. Chan L.-N.L., and Gerhardt E.M. Transferrin receptor gene is hyperexpressed and transcriptionally regulated in differentiating erythroid cells. J. Biol. Chem. 267 (1992) 8254-8259
19. Choi S.O., Cho Y.S., Kim H.L., and Park J.W. ROS mediate the hypoxic repression of the hepcidin gene by inhibiting C/EBPalpha and STAT-3. Biochem. Biophys. Res. Commun. 356 (2007) 312-317
20. Courselaud B., Pigeon C., Inoue Y., Inoue J., Gonzalez F.J., Leroyer P., Gilot D., Boudjema K., Guguen-Guillouzo C., Brissot P., Loreal O., and Ilyin G. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 277 (2002) 41163-41170
21. Dautry-Varsat A., Ciechanover A., and Lodish H.F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 80 (1983) 2258-2262
22. De Domenico I., Ward D.M., Nemeth E., Vaughn M.B., Musci G., Ganz T., and Kaplan J. The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl. Acad. Sci. USA 102 (2005) 8955-8960
23. De Domenico I., Ward D.M., Musci G., and Kaplan J. Iron overload due to mutations in ferroportin. Haematologica 91 (2006) 92-95
24. De Domenico I., Ward D.M., di Patti M.C., Jeong S.Y., David S., Musci G., and Kaplan J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 26 (2007) 2823-2831
25. De Domenico I., Ward D.M., Langelier C., Vaughn M.B., Nemeth E., Sundquist W.I., Ganz T., Musci G., and Kaplan J. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol. Biol. Cell 18 (2007) 2569-2578
26. Delaby C., Pilard N., Goncalves A.S., Beaumont C., and Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood 106 (2005) 3979-3984
27. Donovan A., Brownlie A., Zhou Y., Shepard J., Pratt S.J., Moynihan J., Paw B.H., Drejer A., Barut B., Zapata A., Law T.C., Brugnara C., et al. Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403 (2000) 776-781
28. Donovan A., Lima C.A., Pinkus J.L., Pinkus G.S., Zon L.I., Robine S., and Andrews N.C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1 (2005) 191-200
29. Drakesmith H., Schimanski L.M., Ormerod E., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowley D., Chinthammitr Y., Robson K.J., and Townsend A.R. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin. Blood 106 (2005) 1092-1097
30. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A., Dormishian F., Domingo Jr. R., Ellis M.C., Fullan A., Hinton L.M., Jones N.L., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13 (1996) 399-408
31. Feder J.N., Tsuchihashi Z., Irrinki A., Lee V.K., Mapa F.A., Morikang E., Prass C.E., Starnes S.M., Wolff R.K., Parkkila S., Sly W.S., and Schatzman R.C. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272 (1997) 14025-14028
32. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebron J.A., Watson N., Tsuchihashi Z., Sigal E., Bjorkman P.J., and Schatzman R.C. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. USA 95 (1998) 1472-1477
33. Finch C. Regulators of iron balance in humans. Blood 84 (1994) 1697-1702
34. Flanagan J.M., Peng H., Wang L., Gelbart T., Lee P., Johnson Sasu B., and Beutler E. Soluble transferrin receptor-1 levels in mice do not affect iron absorption. Acta Haematol. 116 (2006) 249-254
35. Flanagan J.M., Truksa J., Peng H., Lee P., and Beutler E. In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol. Dis. 38 (2007) 253-257
36. Fleming M.D., Trenor III C.C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F., and Andrews N.C. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16 (1997) 383-386
37. Fleming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D., and Andrews N.C. Nramp2 is mutated in the anemic Belgrade (b) rat: Evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. USA 95 (1998) 1148-1153
38. Gardenghi S., Marongiu M.F., Ramos P., Guy E., Breda L., Chadburn A., Liu Y., Amariglio N., Rechavi G., Rachmilewitz E.A., Breur W., Cabantchik Z.I., et al. Ineffective erythropoiesis in {beta}-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109 11 (2007) 5027-5035
39. Goldberg M.A., Gaut C.C., and Bunn H.F. Erythropoietin mRNA levels are governed by both the rate of gene transcription and posttranscriptional events. Blood 77 (1991) 271-277
40. Goswami T., and Andrews N.C. Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J. Biol. Chem. 281 (2006) 28494-28498
41. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., and Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388 (1997) 482-488
42. Gunshin H., Fujiwara Y., Custodio A.O., Direnzo C., Robine S., and Andrews N.C. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Invest. 115 (2005) 1258-1266
43. Gunshin H., Starr C.N., Direnzo C., Fleming M.D., Jin J., Greer E.L., Sellers V.M., Galica S.M., and Andrews N.C. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 106 8 (2005) 2879-2883
44. Gutteridge J.M.C., Rowley D.A., and Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochem. J. 199 (1981) 263-265
45. Gutteridge J.M.C., Rowley D.A., Griffiths E., and Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic haemochromatosis. Clin. Sci. 68 (1985) 463-467
46. Hamill R.L., Woods J.C., and Cook B.A. Congenital atransferrinemia: A case report and review of the literature. Am. J. Clin. Pathol. 96 (1991) 215-218
47. Harris Z.L., Takahashi Y., Miyajima H., Serizawa M., MacGillivray R.T., and Gitlin J.D. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 92 (1995) 2539-2543
48. Harris Z.L., Durley A.P., Man T.K., and Gitlin J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 96 (1999) 10812-10817
49. Huang F.W., Pinkus J.L., Pinkus G.S., Fleming M.D., and Andrews N.C. A mouse model of juvenile hemochromatosis. J. Clin. Invest. 115 (2005) 2187-2191
50. Hunter H.N., Fulton D.B., Ganz T., and Vogel H.J. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. 277 (2002) 37597-37603
51. Iolascon A., d'Apolito M., Servedio V., Cimmino F., Piga A., and Camaschella C. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107 (2006) 349-354
52. Jabado N., Canonne-Hergaux F., Gruenheid S., Picard V., and Gros P. Iron transporter Nramp2/DMT-1 is associated with the membrane of phagosomes in macrophages and Sertoli cells. Blood 100 (2002) 2617-2622
53. Jenkins Z.A., Hagar W., Bowlus C.L., Johansson H.E., Harmatz P., Vichinsky E.P., and Theil E.C. Iron homeostasis during transfusional iron overload in beta-thalassemia and sickle cell disease: Changes in iron regulatory protein, hepcidin, and ferritin expression. Pediatr. Hematol. Oncol. 24 (2007) 237-243
54. Johnson M.B., and Enns C.A. Regulation of transferrin receptor 2 by transferrin: Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104 13 (2004) 4287-4293
55. Johnson M.B., Chen J., Murchison N., Green F.A., and Enns C.A. Transferrin receptor 2: Evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol. Biol. Cell 18 (2007) 743-754
56. Kattamis A., Papassotiriou I., Palaiologou D., Apostolakou F., Galani A., Ladis V., Sakellaropoulos N., and Papanikolaou G. The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 91 (2006) 809-812
57. Kawabata H., Yang R., Hirama T., Vuong P.T., Kawano S., Gombart A.F., and Koeffler H.P. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J. Biol. Chem. 274 (1999) 20826-20832
58. Kawabata H., Germain R.S., Vuong P.T., Nakamaki T., Said J.W., and Koeffler H.P. Transferrin receptor 2-{alpha} supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 275 (2000) 16618-16625
59. Kearney S.L., Nemeth E., Neufeld E.J., Thapa D., Ganz T., Weinstein D.A., and Cunningham M.J. Urinary hepcidin in congenital chronic anemias. Pediatr. Blood Cancer 48 (2007) 57-63
60. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
61. Kemna E.H., Tjalsma H., Podust V.N., and Swinkels D.W. Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications. Clin. Chem. 53 (2007) 620-628
62. Klausner R.D., Ashwell G., van Renswoude J., Harford J.B., and Bridges K.R. Binding of apotransferrin to K562 cells: Explanation of the transferrin cycle. Proc. Natl. Acad. Sci. USA 80 (1983) 2263-2266
63. Knutson M., and Wessling-Resnick M. Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 38 (2003) 61-88
64. Kozyraki R., Fyfe J., Verroust P.J., Jacobsen C., Dautry-Varsat A., Gburek J., Willnow T.E., Christensen E.I., and Moestrup S.K. Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc. Natl. Acad. Sci. USA 98 (2001) 12491-12496
65. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., and Adermann K. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480 (2000) 147-150
66. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law S.K., and Moestrup S.K. Identification of the haemoglobin scavenger receptor. Nature 409 (2001) 198-201
67. Kuninger D., Kuns-Hashimoto R., Kuzmickas R., and Rotwein P. Complex biosynthesis of the muscle-enriched iron regulator RGMc. J. Cell Sci. 119 (2006) 3273-3283
68. Lee P., Peng H., Gelbart T., and Beutler E. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc. Natl. Acad. Sci. USA 101 (2004) 9263-9265
69. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc. Natl. Acad. Sci. USA 102 (2005) 1906-1910
70. Lee P.J., Jiang B.H., Chin B.Y., Iyer N.V., Alam J., Semenza G.L., and Choi A.M. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272 (1997) 5375-5381
71. Leung P.S., Srai S.K., Mascarenhas M., Churchill L.J., and Debnam E.S. Increased duodenal iron uptake and transfer in a rat model of chronic hypoxia is accompanied by reduced hepcidin expression. Gut 54 (2005) 1391-1395
72. Levy J.E., Jin O., Fujiwara Y., Kuo F., and Andrews N.C. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21 (1999) 396-399
73. Lin L., Goldberg Y.P., and Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 106 8 (2005) 2884-2889
74. Lin L., Valore E.V., Nemeth E., Goodnough J.B., Gabayan V., and Ganz T. Iron-transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110 6 (2007) 2182-2189
75. Liu X.B., Yang F., and Haile D.J. Functional consequences of ferroportin 1 mutations. Blood Cells Mol. Dis. 35 (2005) 33-46
76. McKie A.T., Marciani P., Rolfs A., Brennan K., Wehr K., Barrow D., Miret S., Bomford A., Peters T.J., Farzaneh F., Hediger M.A., Hentz M.W., et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5 (2000) 299-309
77. McKie A.T., Barrow D., Latunde-Dada G.O., Rolfs A., Sager G., Mudaly E., Mudaly M., Richardson C., Barlow D., Bomford A., Peters T.J., Raja K.B., et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291 (2001) 1755-1759
78. Mims M.P., Guan Y., Pospisilova D., Priwitzerova M., Indrak K., Ponka P., Divoky V., and Prchal J.T. Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105 3 (2004) 1337-1342
79. Monnier P.P., Sierra A., Macchi P., Deitinghoff L., Andersen J.S., Mann M., Flad M., Hornberger M.R., Stahl B., Bonhoeffer F., and Mueller B.K. RGM is a repulsive guidance molecule for retinal axons. Nature 419 (2002) 392-395
80. Muckenthaler M., Roy C.N., Custodio A.O., Minana B., deGraaf J., Montross L.K., Andrews N.C., and Hentze M.W. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat. Genet. 34 (2003) 102-107
81. Muir A., and Hopfer U. Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice. Am. J. Physiol. 248 3Pt1 (1985) G376-G379
82. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
83. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., and Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113 (2004) 1271-1276
84. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., Ganz T., and Kaplan J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
85. Nemeth E., Roetto A., Garozzo G., Ganz T., and Camaschella C. Hepcidin is decreased in TFR2 hemochromatosis. Blood 105 (2005) 1803-1806
86. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., and Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: Structure-function study. Blood 107 (2006) 328-333
87. Nicolas G., Bennoun M., Devaux I., Beaumont C., Grandchamp B., Kahn A., and Vaulont S. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc. Natl. Acad. Sci. USA 98 (2001) 8780-8785
88. Nicolas G., Bennoun M., Porteu A., Mativet S., Beaumont C., Grandchamp B., Sirito M., Sawadogo M., Kahn A., and Vaulont S. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc. Natl. Acad. Sci. USA 99 (2002) 4596-4601
89. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., Beaumont C., Kahn A., and Vaulont S. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110 (2002) 1037-1044
90. Nicolas G., Viatte L., Lou D.Q., Bennoun M., Beaumont C., Kahn A., Andrews N.C., and Vaulont S. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34 (2003) 97-101
91. Niederkofler V., Salie R., and Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J. Clin. Invest. 115 (2005) 2180-2186
92. Oldekamp J., Kramer N., Alvarez-Bolado G., and Skutella T. Expression pattern of the repulsive guidance molecules RGM A, B and C during mouse development. Gene Expr. Patterns 4 (2004) 283-288
93. Oudit G.Y., Sun H., Trivieri M.G., Koch S.E., Dawood F., Ackerley C., Yazdanpanah M., Wilson G.J., Schwartz A., Liu P.P., and Backx P.H. L-type Ca(2+) channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9 (2003) 1187-1194
94. Papanikolaou G., Samuels M.E., Ludwig E.H., MacDonald M.L., Franchini P.L., Dube M.P., Andres L., MacFarlane J., Sakellaropoulos N., Politou M., Nemeth E., Thompson J., et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36 (2004) 77-82
95. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 276 (2001) 7806-7810
96. Peyssonnaux C., Zinkernagel A.S., Schuepbach R.A., Rankin E., Vaulont S., Haase V.H., Nizet V., and Johnson R.S. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J. Clin. Invest. 117 (2007) 1926-1932
97. Pietrangelo A., Dierssen U., Valli L., Garuti C., Rump A., Corradini E., Ernst M., Klein C., and Trautwein C. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132 (2007) 294-300
98. Pigeon C., Ilyin G., Courselaud B., Leroyer P., Turlin B., Brissot P., and Loreal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276 (2001) 7811-7819
99. Poss K.D., and Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. USA 94 (1997) 10919-10924
100. Qiu A., Jansen M., Sakaris A., Min S., Chattopadhyay S., Tsai E., Sandoval C., Zhao R., Akabas M., and Goldman I. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127 5 (2007) 917-928
101. R'Zik S., and Beguin Y. Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Exp. Hematol. 29 (2001) 677-685
102. Raja K.B., Simpson R.J., Pippard M.J., and Peters T.J. In vivo studies on the relationship between intestinal (Fe3+) absorption, hypoxia and erythropoiesis in the mouse. Br. J. Haematol. 68 (1988) 373-378
103. Rivera S., Liu L., Nemeth E., Gabayan V., Sorensen O.E., and Ganz T. Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia. Blood 105 (2005) 1797-1802
104. Rivera S., Nemeth E., Gabayan V., Lopez M.A., Farshidi D., and Ganz T. Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs. Blood 106 (2005) 2196-2199
105. Robb A., and Wessling-Resnick M. Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104 (2004) 4294-4299
106. Rodriguez A., Pan P., and Parkkila S. Expression studies of neogenin and its ligand hemojuvelin in mouse tissues. J. Histochem. Cytochem. 55 (2007) 85-96
107. Roetto A., Papanikolaou G., Politou M., Alberti F., Girelli D., Christakis J., Loukopoulos D., and Camaschella C. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33 (2003) 21-22
108. Rolfs A., Kvietikova I., Gassmann M., and Wenger R.H. Oxygen-regulated transferring expression is mediated by hypoxia-inducible factor-1. J. Biol. Chem. 272 (1997) 20055-20062
109. Roy C.N., Weinstein D.A., and Andrews N.C. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: The molecular biology of the anemia of chronic disease: A hypothesis. Pediatr. Res. 53 (2003) 507-512
110. Roy C.N., Custodio A.O., de Graaf J., Schneider S., Akpan I., Montross L.K., Sanchez M., Gaudino A., Hentze M.W., Andrews N.C., and Muckenthaler M.U. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nat. Genet. 36 (2004) 481-485
111. Roy C.N., Mak H.H., Akpan I., Losyev G., Zurakowski D., and Andrews N.C. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109 (2007) 4038-4044
112. Sacher A., Cohen A., and Nelson N. Properties of the mammalian and yeast metal-ion transporters DCT1 and Smf1p expressed in Xenopus laevis oocytes. J. Exp. Biol. 204 (2001) 1053-1061
113. Samad T.A., Rebbapragada A., Bell E., Zhang Y., Sidis Y., Jeong S.J., Campagna J.A., Perusini S., Fabrizio D.A., Schneyer A.L., Lin H.Y., Brivanlou A.H., et al. DRAGON: A bone morphogenetic protein co-receptor. J. Biol. Chem. 280 14 (2005) 14122-14129
114. Schimanski L.M., Drakesmith H., Merryweather-Clarke A.T., Viprakasit V., Edwards J.P., Sweetland E., Bastin J.M., Cowley D., Chinthammitr Y., Robson K.J., and Townsend A.R. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105 10 (2005) 4096-4102
115. Schofield C.J., and Ratcliffe P.J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 338 (2005) 617-626
116. Sham R.L., Phatak P.D., West C., Lee P., Andrews C., and Beutler E. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features. Blood Cells Mol. Dis. 34 (2005) 157-161
117. Shaw G.C., Cope J.J., Li L., Corson K., Hersey C., Ackermann G.E., Gwynn B., Lambert A.J., Wingert R.A., Traver D., Trede N.S., Barut B.A., et al. Mitoferrin is essential for erythroid iron assimilation. Nature 440 (2006) 96-100
118. Shayeghi M., Latunde-Dada G.O., Oakhill J.S., Laftah A.H., Takeuchi K., Halliday N., Khan Y., Warley A., McCann F.E., Hider R.C., Frazer D.M., Anderson G.J., et al. Identification of an intestinal heme transporter. Cell 122 (2005) 789-801
119. Sheftel A.D., Zhang A.S., Brown C., Shirihai O.S., and Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110 (2007) 125-132
120. Shike H., Lauth X., Westerman M.E., Ostland V.E., Carlberg J.M., Van Olst J.C., Shimizu C., Bulet P., and Burns J.C. Bass hepcidin is a novel antimicrobial peptide induced by bacterial challenge. Eur. J. Biochem. 269 (2002) 2232-2237
121. Silvestri L., Pagani A., Fazi C., Gerardi G., Levi S., Arosio P., and Camaschella C. Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 109 (2007) 4503-4510
122. Su M.A., Trenor C.C., Fleming J.C., Fleming M.D., and Andrews N.C. The G185R mutation disrupts function of the iron transporter Nramp2. Blood 92 (1998) 2157-2163
123. Townsend A., and Drakesmith H. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload. Lancet 359 (2002) 786-790
124. Trenor III C.C., Campagna D.R., Sellers V.M., Andrews N.C., and Fleming M.D. The molecular defect in hypotransferrinemic mice. Blood 96 (2000) 1113-1118
125. Truksa J., Peng H., Lee P., and Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. USA 103 (2006) 10289-10293
126. Verga Falzacappa M.V., Vujic Spasic M., Kessler R., Stolte J., Hentze M.W., and Muckenthaler M.U. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 109 (2007) 353-358
127. Viatte L., Lesbordes-Brion J.C., Lou D.Q., Bennoun M., Nicolas G., Kahn A., Canonne-Hergaux F., and Vaulont S. Deregulation of proteins involved in iron metabolism in hepcidin-deficient mice. Blood 105 12 (2005) 4861-4864
128. Vulpe C.D., Kuo Y.M., Murphy T.L., Cowley L., Askwith C., Libina N., Gitschier J., and Anderson G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21 (1999) 195-199
129. Wallace D.F., Dixon J.L., Ramm G.A., Anderson G.J., Powell L.W., and Subramaniam V.N. A novel mutation in ferroportin implicated in iron overload. J. Hepatol. 46 (2007) 921-926
130. Wang R.H., Li C., Xu X., Zheng Y., Xiao C., Zerfas P., Cooperman S., Eckhaus M., Rouault T., Mishra L., and Deng C.X. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2 (2005) 399-409
131. Watson C.J. Stat transcription factors in mammary gland development and tumorigenesis. J. Mammary Gland Biol. Neoplasia 6 (2001) 115-127
132. Weinberg E.D. Iron and infection. Microbiol. Rev. 45 1 (1978) 45-66
133. Weinstein D.A., and Wolfsdorf J.I. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur. J. Pediatr. 161 (2002) S35-S39
134. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
135. Weiss G., and Goodnough L.T. Anemia of chronic disease. N. Engl. J. Med. 352 (2005) 1011-1023
136. Weizer-Stern O., Adamsky K., Amariglio N., Levin C., Koren A., Breuer W., Rachmilewitz E., Breda L., Rivella S., Cabantchik Z.I., and Rechavi G. Downregulation of hepcidin and haemojuvelin expression in the hepatocyte cell-line HepG2 induced by thalassaemic sera. Br. J. Haematol. 135 (2006) 129-138
137. Weizer-Stern O., Adamsky K., Amariglio N., Rachmilewitz E., Breda L., Rivella S., and Rechavi G. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models. Am. J. Hematol. 81 (2006) 479-483
138. West Jr. A.P., Bennett M.J., Sellers V.M., Andrews N.C., Enns C.A., and Bjorkman P.J. Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J. Biol. Chem. 275 (2000) 38135-38138
139. Wolfsdorf J.I., and Crigler J.F. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease. J. Pediatr. Gastroenterol. Nutr. 29 (1999) 136-143
140. Wrighting D.M., and Andrews N.C. Interleukin-6 induces hepcidin expression through STAT3. Blood 108 (2006) 3204-3209
141. Xu H., Jin J., DeFelice L.J., Andrews N.C., and Clapham D.E. A spontaneous, recurrent mutation in divalent metal transporter-1 exposes a calcium entry pathway. PLoS Biol. 2 (2004) E50
142. Yachie A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., Ohta K., Kasahara Y., and Koizumi S. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J. Clin. Invest. 103 (1999) 129-135
143. Yang J., Goetz D., Li J.Y., Wang W., Mori K., Setlik D., Du T., Erdjument-Bromage H., Tempst P., Strong R., and Barasch J. An iron delivery pathway mediated by a lipocalin. Mol. Cell 10 (2002) 1045-1056
144. Zhang A.S., West Jr. A.P., Wyman A.E., Bjorkman P.J., and Enns C.A. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J. Biol. Chem. 280 (2005) 33885-33894
145. Zhang A.S., Anderson S.A., Meyers K.R., Hernandez C., Eisenstein R.S., and Enns C.A. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J. Biol. Chem. 282 (2007) 12547-12556
146. Zohn I.E., De Domenico I., Pollock A., Ward D.M., Goodman J.F., Liang X., Sanchez A.J., Niswander L., and Kaplan J. The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease. Blood 109 (2007) 4174-4180
147. Zoller H., and Cox T.M. Hemochromatosis: Genetic testing and clinical practice. Clin. Gastroenterol. Hepatol. 3 (2005) 945-958
148. Zoller H., McFarlane I., Theurl I., Stadlmann S., Nemeth E., Oxley D., Ganz T., Halsall D.J., Cox T.M., and Vogel W. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease. Hepatology 42 (2005) 466-472